These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35568790)

  • 21. KEAP1/NRF2 axis regulates H
    He J; Zhang X; Lian C; Wu J; Fang Y; Ye X
    Gene; 2019 Apr; 691():8-17. PubMed ID: 30594636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal amplification in the KEAP1-NRF2-ARE antioxidant response pathway.
    Liu S; Pi J; Zhang Q
    Redox Biol; 2022 Aug; 54():102389. PubMed ID: 35792437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway.
    Baird L; Yamamoto M
    Mol Cell Biol; 2020 Jun; 40(13):. PubMed ID: 32284348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piceatannol induces heme oxygenase-1 expression in human mammary epithelial cells through activation of ARE-driven Nrf2 signaling.
    Lee HH; Park SA; Almazari I; Kim EH; Na HK; Surh YJ
    Arch Biochem Biophys; 2010 Sep; 501(1):142-50. PubMed ID: 20558128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway.
    Galiè M; Costanzo M; Nodari A; Boschi F; Calderan L; Mannucci S; Covi V; Tabaracci G; Malatesta M
    Free Radic Biol Med; 2018 Aug; 124():114-121. PubMed ID: 29864481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
    Nezu M; Suzuki N; Yamamoto M
    Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of an adaptor protein that facilitates Nrf2-Keap1 complex formation and modulates antioxidant response.
    Zhang Y; Hou Y; Liu C; Li Y; Guo W; Wu JL; Xu D; You X; Pan Y; Chen Y
    Free Radic Biol Med; 2016 Aug; 97():38-49. PubMed ID: 27212020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
    Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Inducers and Inhibitors of the Keap1/Nrf2/ARE System on the Viability and Functional Activity of Model Neuronal-Like and Glial Cells.
    Menshchikova EB; Chechushkov AV; Kozhin PM; Romakh LP; Serykh AE; Khrapova MV; Petrova ES; Kandalintseva NV
    Bull Exp Biol Med; 2024 Jan; 176(3):332-337. PubMed ID: 38340195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Punicalagin attenuates palmitate-induced lipotoxicity in HepG2 cells by activating the Keap1-Nrf2 antioxidant defense system.
    Yan C; Sun W; Wang X; Long J; Liu X; Feng Z; Liu J
    Mol Nutr Food Res; 2016 May; 60(5):1139-49. PubMed ID: 26989875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy.
    Adelusi TI; Du L; Hao M; Zhou X; Xuan Q; Apu C; Sun Y; Lu Q; Yin X
    Biomed Pharmacother; 2020 Mar; 123():109732. PubMed ID: 31945695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
    Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
    J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse model.
    Moretti D; Tambone S; Cerretani M; Fezzardi P; Missineo A; Sherman LT; Munoz-Sajuan I; Harper S; Dominquez C; Pacifici R; Tomei L; Park L; Bresciani A
    Free Radic Biol Med; 2021 Jan; 162():243-254. PubMed ID: 33096251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
    Zgorzynska E; Dziedzic B; Walczewska A
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Nrf2-Keap1-ARE signal pathway in traumatic lung injury and functional study.
    Hu LY; Cui JB; Xu XM; Huang ZH; Jiao HT
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1402-1408. PubMed ID: 29565500
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Nabeshima T; Hamada S; Taguchi K; Tanaka Y; Matsumoto R; Yamamoto M; Masamune A
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G419-G427. PubMed ID: 31961719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress.
    Suzuki T; Yamamoto M
    J Biol Chem; 2017 Oct; 292(41):16817-16824. PubMed ID: 28842501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keap1-Nrf2 signaling pathway in angiogenesis and vascular diseases.
    Guo Z; Mo Z
    J Tissue Eng Regen Med; 2020 Jun; 14(6):869-883. PubMed ID: 32336035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nrf2-Keap1 antioxidant defense and cell survival signaling are upregulated by 17β-estradiol in homocysteine-treated dopaminergic SH-SY5Y cells.
    Chen CS; Tseng YT; Hsu YY; Lo YC
    Neuroendocrinology; 2013; 97(3):232-41. PubMed ID: 22948038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New insights into the mechanism of Keap1-Nrf2 interaction based on cancer-associated mutations.
    Cheng L; Wang H; Li S; Liu Z; Wang C
    Life Sci; 2021 Oct; 282():119791. PubMed ID: 34229009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.